[{"orgOrder":0,"company":"KeyBioscience","sponsor":"Eli Lilly | Nordic Bioscience | Profil Institut f\u00fcr Stoffwechselforschung GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SWITZERLAND","productType":"Undisclosed","year":"2019","type":"Inapplicable","leadProduct":"KBP","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Phase I","graph3":"KeyBioscience","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Injection","sponsorNew":"KeyBioscience \/ Eli Lilly | Nordic Bioscience | Profil Institut f\u00fcr Stoffwechselforschung GmbH","highestDevelopmentStatusID":"6","companyTruncated":"KeyBioscience \/ Eli Lilly | Nordic Bioscience | Profil Institut f\u00fcr Stoffwechselforschung GmbH"},{"orgOrder":0,"company":"KeyBioscience","sponsor":"Nordic Bioscience","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SWITZERLAND","productType":"Undisclosed","year":"2017","type":"Inapplicable","leadProduct":"KBP-042","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Phase II","graph3":"KeyBioscience","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Injection","sponsorNew":"KeyBioscience \/ Nordic Bioscience","highestDevelopmentStatusID":"8","companyTruncated":"KeyBioscience \/ Nordic Bioscience"},{"orgOrder":0,"company":"KeyBioscience","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"SWITZERLAND","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"KBP-336","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Phase II","graph3":"KeyBioscience","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Injection","sponsorNew":"KeyBioscience \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"KeyBioscience \/ Undisclosed"},{"orgOrder":0,"company":"KeyBioscience","sponsor":"Eli Lilly","pharmaFlowCategory":"D","therapeuticArea":"Nutrition and Weight Loss","country":"SWITZERLAND","productType":"Miscellaneous","year":"2024","type":"Expanded Collaboration","leadProduct":"LY3541105","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Phase I","graph3":"KeyBioscience","amount2":1.3999999999999999,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":1.3999999999999999,"dosageForm":"Undisclosed","sponsorNew":"KeyBioscience \/ Eli Lilly","highestDevelopmentStatusID":"6","companyTruncated":"KeyBioscience \/ Eli Lilly"}]